Keywords: Chronic lymphocytic leukemia; Small lymphocytic lymphoma; CLL; Melanoma; Immune checkpoint inhibitors; Pembrolizumab; PD-1 inhibitor;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Ibrutinib; Mathematical models; Clonal architecture; Venetoclax; CLL; Therapy resistance;
Keywords: Smudge cells; CLL;
Keywords: chronic lymphocytic leukemia; CLL; primary care; targeted therapies; tumor biology;
Keywords: ALL; acute lymphoid leukemia; AML; acute myeloid leukemia; CLL; chronic lymphoid leukemia; CML; chronic myeloid leukemia; Hb; hemoglobin; WBC; white blood cell;
Keywords: 5-Aza; 5-Aza-2-deoxycytidine; ALL; acute lymphoblastic leukemia; AML; acute myeloid leukemia; BIR; baculoviral inhibitor of apoptosis repeat; CAD; caspase-activated deoxyribonuclease; CDK; cyclin-dependent kinase; cIAP; cellular inhibitor of apoptosis; CL
Keywords: VTE; venous thromboembolism; HSCT; hematopoietic stem cell transplant; LMWH; low molecular weight heparin; IMIDs; immunomodulatory drugs; AML; acute myeloid leukemia; IQR; interquartile range; TAT; thrombin antithrombin; FVII; factor VII; FVIII; factor VI
Keywords: EV; extracellular vesicles; ILVs; intraluminal vesicles; BMSCs; bone marrow stromal cells; AML; acute myeloid leukemia; CML; chronic myelogenous leukemia; CLL; chronic lymphocytic leukemia; ALL; acute lymphoblastic leukemia; EGF; epidermal growth factor;
Keywords: CLL; Metabolism; PK M2; LDH; High-risk;
Keywords: chronic lymphocytic leukemia; CLL; primary care; targeted therapies; tumor biology;
Keywords: ABC; activated-B Cell; BTK; Bruton's tyrosine kinase; CNS; Central nervous system; CLL; chronic lymphocytic leukemia; DLBCL; Diffuse Large B-cell lymphoma; DAB; diaminobenzidin; DNMT; DNA methyltransferase; GO; gene ontology; GCB; germinal center cell lik
Keywords: Chronic lymphocytic leukemia; CLL; Ibrutinib; Idelalisib; Venetoclax; Targeted therapy;
Keywords: AIHA; autoimmune hemolytic anemia; B2M; β2-microglobulin; BR; bendamustine and rituximab; BTK; Bruton tyrosine kinase; CLL; chronic lymphocytic leukemia; CR; complete remission; FCR; fludarabine; cyclophosphamide; and rituximab; FISH; fluorescence in sit
Keywords: CLL; MTM; BandStop filter;
Keywords: 5-FU; 5-fluorouracil; AF; atrial fibrillation; ALK; anaplastic lymphoma kinase; APD; action potential duration; APL; acute promyelocytic leukemia; BCR-ABL; breakpoint cluster region-Abelson; BTK; Bruton tyrosine kinase; CD20; cluster of differentiation 20
Keywords: CLL; Complementary and alternative medicine; Herbal medicine; Leukemia; Lymphoma;
Keywords: FK228 (PubChem CID: 5352062); PXD101 (PubChem CID: 6918638); SAHA (PubChem CID: 5311); LBH-589 (PubChem CID: 6918837); tubacin (PubChem CID: 6675804); tubastatin A (PubChem CID: 49850262); ACY-1215 (PubChem CID: 53340666); ACY-241 (PubChem CID: 53340426);
Keywords: BMZ; betamethasone; BSID; Bayley Scales of Infant Development, Third Edition; CCAM; congenital cystic adenomatoid malformation; CLL; congenital lung lesion; ECMO; extracorporeal membrane oxygenation; EXIT; ex utero intrapartum therapy; NICU; neonatal inte
Keywords: AYL; type AY from Candida cylindracea; BDO; 1,4-butanediol; [C4mim][BF4]; 1-butyl-3-methylimidazolium tetrafluoroborate; [C4mim][NTf2]; 1-butyl-3-methylimidazolium bis(trifluoromethylsulfonyl)amide; [C4mim][PF6]; 1-butyl-3-methylimidazolium hexafluorophos
Keywords: ALL; acute lymphoblastic leukemia; AML; acute myeloid leukemia; CLL; B-cell chronic lymphocytic leukemia; CML; chronic myelogenous leukemia; ERK; extracellular signal-regulated kinase; FN3; fibronectin type-III (domain); GBM; glioblastoma multiforme; JMML
Keywords: ADP; mono-adenosine diphosphate; ATP; adenosine triphosphate; BC; breast cancer; BMI; body mass index; Cdks; cyclin-dependent kinases; C.I.; confidence interval; CLL; chronic lymphocytic leukemia; CRP; C-reactive protein; CtBPs; mammalian COOH-terminal bi
Keywords: CLL; MPGN; Obinutuzumab; Renal failure;
Keywords: Chronic lymphocytic leukemia; CLL; Older adults; Targeted therapy;
Keywords: γc; common gamma chain, CD132; IL; interleukin; sγc; soluble form of common gamma chain; JAK; Janus-activated kinase; STAT; signal transducer and activator of transcription; T-ALL; T-cell acute lymphocytic leukemia; B-ALL; B-cell acute lymphocytic leuke
Keywords: ET-1; Endothelin-1; CLL; Chronic Lymphocytic Leukemia; ETAR; Endothelin receptor type A; TLR; Toll-like receptor; PBMC; peripheral blood mononuclear cell; GAPDH; Glyceraldehyde 3-phosphate dehydrogenase; MSP; Methylation Specific PCR; FBS; Fetal bovine se
Keywords: ASH; American Society of Hematology; ATAP; amphipathic tail-anchoring peptide; BAD; BCL-2-associated death promoter protein; BAK; BCL-2 homologous antagonist killer; BAX; BCL-2-associated X protein; BCL-2; B-cell lymphoma 2; BCL-w (BCL2L2); BCL-2-like pro
Keywords: Natural (auto) antibodies; Chicken; Selection lines; Western blot; CLL; chicken-liver-cell-lysate; NAAb; natural (auto-) antibodies;
Keywords: APTMS; 3-aminopropyltriethoxysilane; 8-OHdG; 8-hydroxydeoxyguanosine; BRE; Bio-recognition element; BRCA-1; Breast cancer 1 gene; CNTs; Carbon nanotubes; CLL; Chronic lymphocytic leukemia; EIS; Electrochemical impedance spectroscopy; ELISA; Enzyme linked
Keywords: CLL; Drug toxicity; Hepatitis; Hepatomegaly; Liver;
Keywords: AML; acute myeloid leukemia; CAK; CDK-activating kinase; CDK; cyclin-dependent kinases; CLL; chronic lymphocytic leukemia; CT; RNA polymerase II C-terminal domain; DLT; dose-limiting toxicities; DSIF; DRB-sensitivity inducing factor; ER; estrogen Receptor
Keywords: Bendamustine; CLL; Ibrutinib; Idelalisib; Obinutuzumab; Venetoclax;
Keywords: AML; acute myeloid leukemia; BRCA; breast cancer; BRCC3; BRCA1/BRCA2-Containing Complex Subunit 3; C; constant; CLL; chronic lymphocytic leukemia; CML; chronic myeloid leukemia; CSC; cancer stem-like cell; EGFR; epidermal growth factor receptor; EMT; epit
Keywords: AE; adverse event; AML; acute myeloid leukemia; APC; anaphase promoting complex; CLL; chronic lymphocytic leukemia; CPC; chromosomal passenger complex; CR; complete response; CRi; complete remission with incomplete blood count recovery; FDA; Food and Drug
Keywords: ALT; alternative lengthening of telomeres; BP; base pair; CLL; chronic lymphatic leukemia; CSS; cancer specific survival; CI; Confidence interval; DFS; disease free survival; EFS; event free survival; FISH; fluorescent in situ hybridization; GEP-NET; gast
Keywords: BEN; bendamustine; CI; combination index; CLB; chlorambucil; CLL; chronic lymphocytic leukemia; Cyclo; cyclophosphamide; dADO; deoxyadenosine; Del; deletion; DHE; dihydroethidium; DiOC6; 3,3â²-dihexyloxacarbocyanine iodide; DMSO; dimethyl sulfoxide; DR;
Keywords: Ag; antigen; bnAb; broadly neutralizing anti-HIV Ig; CLL; chronic lymphocytic leukemia; EBV; Epstein Barr virus; GBM; glomerular basement membrane; GN; glomerulonephritis; GP; Goodpasture; GPS; GP syndrome; HC; heavy chain; HCDR3; heavy chain complementar
Keywords: CLL; Prognostic markers; Prognostic index; Chromosomal abnormalities; Genetic mutations;
Keywords: ALL; Acute lymphoblastic leukemia; AML; Acute myeloid leukemia; ATF6α; Activating transcription factor 6 alpha (also referred as ATF6); CHOP; C/EBP homologous protein; CLL; Chronic lymphoblastic leukemia; DCs; Dendritic cells; ER; Endoplasmic reticulum;
Keywords: CLL; NGS; Genomics; Epigenomics; Non-coding; Clonal evolution;
Keywords: AA; accelerated approval; ALL; acute lymphoblastic leukemia; CCyR; complete cytogenetic response; CLL; chronic lymphocytic lymphoma; CML; chronic myeloid leukemia; CRC; colorectal carcinoma; CR; complete response; CRi; complete response with incomplete bl
Keywords: ALK; anaplastic lymphoma kinase; ALL; acute lymphoblastic leukemia; CLL; chronic lymphocytic leukemia; CML; chronic myelogenous leukemia; CNS; central nervous system; CRC; colorectal cancer; DTC; differentiated thyroid carcinoma; DUSP; dual specificity ph
Keywords: AML; Acute myeloid leukemia; CAS; Cellular apoptosis susceptibility; CLL; Chronic lymphocytic leukemia; CML; Chronic myeloid leukemia; CRM1; Chromosome region maintenance 1; NES; Nuclear export signal; NF-κB; Nuclear factor-κB; NLS; Nuclear localizing s
Keywords: DEPC; 1,2-dierucoyl-sn-glycero-3-phosphocholine; DMPG; 1,2-ditetradecanoyl-sn-glycero-3-phospho-(1â²-rac-glycerol); DSPC; 1,2-dioctadecanoyl-sn-glycero-3-phosphocholine; DOTAP; 1,2-dioleoyl-3-trimethylammonium-propane; DPPC; 1,2-dipalmitoyl-sn-glycero-3-
Keywords: CLL; Molecular drivers; Pathogenicity; Prognosis; Therapy;
Keywords: Breast carcinoma; Breast MRI; CLL; Lymphoma; Lymphoproliferative disorder;
Keywords: AML; acute myeloid leukemia; CI; Confidence Interval; CLL; chronic lymphocytic leukemia; CML; chronic myeloid leukemia; IRB; Institutional Review Board; MDS; myelodysplastic syndrome; Non-CLL; non-chronic lymphocytic leukemia; OR; odds ratio; RADRUE; Real
Keywords: Hematologic malignancy; Hypereosinophilia; Hypereosinophilic syndrome; Lymphoma; Leukemia; AICL; Angioimmunoblastic T-cell leukemia; AML; Acute myelogenous leukemia; ATLL; Adult T-cell lymphoma/leukemia; BE; Blood eosinophilia; CEL; Chronic eosinophilic l
Keywords: CLL; cMBL; IGHV; Prognosis; TTFT
Keywords: BMI; body mass index; Cas; cases; CLL; chronic lymphocytic leukaemia; ctrl; controls; DLBCL; diffuse large B-cell lymphoma; EPIC; European prospective investigation of diet and cancer; FL; follicular lymphoma; HCAs; heterocyclic amines; HL; Hodgkin lympho
Keywords: CLL; Apoptosis reactivation; Targeting proteins regulating apoptosis; Bcl-2 family; IAP proteins; BH3 mimetics